Potassium Ion

Potassium Ion

SCHEMBL711352

CC[O-].C[O-].[K+].[K+]

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

AGTR1DHFRGABBR1GABBR2GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGARTNR3C2PBP2XPTGS1PTGS2VKORC1blablaT-3blaT-4blaT-5blaT-6dacAdacBdacCfolAftsImrcAmrcBmrdApbp1apbp1bpbp2apbp2bpbp3polthyA

The experimentally established mechanism targets of Potassium Ion. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Potassium Ion SCHEMBL5681668 0.94
Potassium Ion SCHEMBL27601255 0.94
Potassium Ion SCHEMBL9251 0.94
SCHEMBL7514271 0.88
SCHEMBL7515117 0.88
Zinc Ion SCHEMBL10775470 0.88
Water SCHEMBL6221789 0.88
SCHEMBL825463 0.88
SCHEMBL2696970 0.88
SCHEMBL9314393 0.88

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2289968-B1 Polyester process XEROX CORP (US) 2016-04-27 EP claimed
US-8466254-B2 Polyester process XEROX CORPORATION (US) 2013-06-18 US claimed
US-20120283392-A1 POLYESTER PROCESS XEROX CORPORATION (US) 2012-11-08 US claimed
US-20110053079-A1 POLYESTER PROCESS XEROX CORPORATION (US) 2011-03-03 US claimed
EP-2289968-A1 Polyester process Xerox Corporation (US) 2011-03-02 EP claimed
US-6063827-A Polyester process XEROX CORPORATION (US) 2000-05-16 US claimed
EP-4638652-A1 A METHOD FOR THE PRODUCTION OF A LIGNIN OIL Votion Biorefineries AB (SE) 2025-10-29 EP disclosed
WO-2024132813-A1 A METHOD FOR THE PRODUCTION OF A LIGNIN OIL VOTION BIOREFINERIES AB (SE) 2024-06-27 WO disclosed
EP-2289968-B1 Polyester process XEROX CORP (US) 2016-04-27 EP disclosed
US-8466254-B2 Polyester process XEROX CORPORATION (US) 2013-06-18 US disclosed
US-20120283392-A1 POLYESTER PROCESS XEROX CORPORATION (US) 2012-11-08 US disclosed
US-8257899-B2 Polyester process XEROX CORPORATION (US) 2012-09-04 US disclosed
US-8124813-B2 Method of producing 2-phenoxyacetals and the corresponding 2-phenoxy-carbaldehydes therefrom SALTIGO GMBH (DE) 2012-02-28 US disclosed
US-6127080-A TONER COMPRISED OF COLORANT AND POLYESTER FORMED BY REACTING ORGANIC DIOL WITH CYCLIC ALKYLENE CARBONATE IN PRESENCE OF FIRST CATALYST, ADDING FURTHER CARBONATE IN PRESENCE OF SECOND CATALYST, CONDENSING WITH DICARBOXYLIC ACID XEROX CORPORATION (US) 2000-10-03 US disclosed
US-6063827-A Polyester process XEROX CORPORATION (US) 2000-05-16 US disclosed
EP-0974612-A2 Preparation of unsaturated polyether esters Xerox Corporation (US) 2000-01-26 EP disclosed
EP-0430114-A2 Hexahydro-1H-quino[4,3,2-ef][1,4]benzoxazepines and related compounds, a process and intermediates for their preparation and their use as medicaments HOECHST-ROUSSEL PHARMACEUTICALS INCORPORATED (US) 1991-06-05 EP disclosed
US-4719210-A 3-vinyl and 3-thyinyl-beta-carbolines, and their use as benzodiazepine receptor antagonists or agonists SCHERING AKTIENGESELLSCHAFT (DE) 1988-01-12 US disclosed
US-4367238-A ANTIINFLAMMATORY AGENTS, ANALGESICS FUJISAWA PHARMACEUTICAL COMPANY, LTD. (JP) 1983-01-04 US disclosed
EP-0033614-A1 Phenylalkanoic acid derivatives, processes for the preparation thereof and pharmaceutical compositions containing them FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1981-08-12 EP disclosed